BiotechTube
Home/BioMimetix JV/John Wetzel, PhD
JW

John Wetzel, PhD

Director, Chemistry, Manufacturing and Controls

BioMimetix JV

Therapeutic Areas

OncologyInflammatory Diseases

BioMimetix JV Pipeline

DrugIndicationPhase
BMX-001High-Grade GliomaPhase 3 (preparing)

Leadership Team at BioMimetix JV

JC
James Crapo, MD
CEO
RH
Rob Hellewell
President & Chief Business Officer
DS
David S Silberstein, PhD
VP of R&D
SG
Shayne Gad, PhD
VP of Drug Safety, Regulatory Affairs
RO
Robert Ogden, CPA
CFO
SP
Sara Penchev
Director of Clinical Operations
View full BioMimetix JV profile